EUVIMEDEUVIMED entdecken
Multizentrische Studie

Long-Term Outcomes of a Japanese Prospective Multicenter Registry Using a Heparin-Bonded Expanded Polytetrafluoroethylene Graft for Above-the-Knee Femoropopliteal Bypasses

Naoki Fujimura, Hideaki Obara, Kentaro Matsubara, Naoki Toya, Naoko Isogai, Hidemitsu Ogino, Taku Fujii, Toshifumi Kudo, Yuji Kanaoka, Hirohisa Harada, Hidetoshi Uchiyama, Atsushi Guntani und 5 weitere

Circulation Journal · 2024

DOI: 10.1253/circj.cj-24-0135 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation Journal, 2024. Verfasst von Naoki Fujimura und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Saiseikai Central Hospital. Hauptthemen laut MEDLINE: Blood Vessel Prosthesis, Femoral Artery, Heparin, Peripheral Arterial Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Despite the widespread use of PROPATEN®, a bioactive heparin-bonded expanded polytetrafluoroethylene graft, in bypass surgery, there are only a few reports of long-term results. We evaluated the long-term results of PROPATEN®use for above-knee femoropopliteal bypass (AKFPB). METHODS AND RESULTS: After PROPATEN®-based AKFPB, patients were prospectively registered at 20 Japanese institutions between July 2014 and October 2017 to evaluate long-term results. During the median follow-up of 76 months (interquartile range 36-88 months) for 120 limbs (in 113 patients; mean [±SD] age 72.7±8.1 years; 66.7% male; ankle-brachial index [ABI] 0.45±0.27; lesion length 26.2±5.7 cm; chronic limb-threatening ischemia in 45 limbs), there were 8 major amputations; however, clinical improvement was sustained (mean [±SD] ABI 0.87±0.23) and the Rutherford classification grade improved in 105 (87.5%) limbs at the latest follow-up. At 8 years, the primary patency, freedom from target-lesion revascularization, secondary patency, survival, and amputation-free survival, as estimated by the Kaplan-Meier method, were 66.3±4.8%, 71.5±4.4%, 86.5±3.4%, 53.1±5.0%, and 47.4±5.3%, respectively. CONCLUSIONS: This multicenter prospective registry-based analysis showed sustained excellent clinical improvement and secondary patency for up to 8 years following PROPATEN®-based AKFPB. PROPATEN®constitutes a durable and good revascularization option for complex superficial femoral artery lesions, especially when endovascular treatment is inappropriate or an adequate venous conduit is unavailable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Vessel ProsthesisFemoral ArteryHeparinPeripheral Arterial DiseasePolytetrafluoroethylenePopliteal ArteryVascular PatencyAgedAged, 80 and overFemaleHumansMaleMiddle AgedAmputation, SurgicalBlood Vessel Prosthesis ImplantationCoated Materials, BiocompatibleEast Asian PeopleJapanLimb SalvageProspective StudiesProsthesis DesignRegistriesTime FactorsTreatment Outcome

Stichwörter der Autor:innen

Above-the-knee femoropopliteal bypassBioactive heparin-bonded expanded polytetrafluoroethylene graftLower extremity arterial diseasePROPATEN®

Substanzen

Coated Materials, BiocompatibleHeparinPolytetrafluoroethylene

Autor:innen und Institutionen

  • Department of Vascular Surgery, Saiseikai Central Hospital.
  • Department of Surgery, Keio University School of Medicine.
  • Department of Surgery, The Jikei University Kashiwa Hospital.
  • Department of Surgery, Shonan Kamakura General Hospital.
  • Department of Surgery, Narita Tomisato Tokushukai Hospital.
  • Department of Surgery, Saitama Municipal Hospital.

Zitieren

APA

Fujimura, N., Obara, H., Matsubara, K., Toya, N., Isogai, N., Ogino, H., Fujii, T., Kudo, T., Kanaoka, Y., Harada, H., Uchiyama, H., Guntani, A., Shimogawara, T., Watada, S., Shibutani, S., Ohki, T., & Japanese Bypass Registry Group (2024). Long-Term Outcomes of a Japanese Prospective Multicenter Registry Using a Heparin-Bonded Expanded Polytetrafluoroethylene Graft for Above-the-Knee Femoropopliteal Bypasses. Circulation Journal. https://doi.org/10.1253/circj.cj-24-0135

Vancouver

Fujimura N, Obara H, Matsubara K, Toya N, Isogai N, Ogino H, et al. Long-Term Outcomes of a Japanese Prospective Multicenter Registry Using a Heparin-Bonded Expanded Polytetrafluoroethylene Graft for Above-the-Knee Femoropopliteal Bypasses. Circulation Journal. 2024. doi:10.1253/circj.cj-24-0135

BibTeX
@article{Fujimura2024,
  author = {Fujimura, Naoki and Obara, Hideaki and Matsubara, Kentaro and Toya, Naoki and Isogai, Naoko and Ogino, Hidemitsu and Fujii, Taku and Kudo, Toshifumi and Kanaoka, Yuji and Harada, Hirohisa and Uchiyama, Hidetoshi and Guntani, Atsushi and Shimogawara, Tatsuya and Watada, Susumu and Shibutani, Shintaro and Ohki, Takao and Japanese Bypass Registry Group, Japanese Bypass Registry Group},
  title = {Long-Term Outcomes of a Japanese Prospective Multicenter Registry Using a Heparin-Bonded Expanded Polytetrafluoroethylene Graft for Above-the-Knee Femoropopliteal Bypasses},
  journal = {Circulation Journal},
  year = {2024},
  doi = {10.1253/circj.cj-24-0135}
}
Kostenlos starten →